Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Common Equity (2016 - 2025)

Aspen Aerogels' Common Equity history spans 13 years, with the latest figure at $235.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity fell 61.69% year-over-year to $235.5 million, compared with a TTM value of $235.5 million through Dec 2025, down 61.69%, and an annual FY2025 reading of $235.5 million, down 61.69% over the prior year.
  • Common Equity for Q4 2025 was $235.5 million at Aspen Aerogels, down from $305.7 million in the prior quarter.
  • The five-year high for Common Equity was $614.7 million in Q4 2024, with the low at $66.6 million in Q1 2021.
  • Average Common Equity over 5 years is $325.4 million, with a median of $311.8 million recorded in 2025.
  • Year-over-year, Common Equity soared 248.45% in 2022 and then tumbled 61.69% in 2025.
  • Tracing ASPN's Common Equity over 5 years: stood at $128.4 million in 2021, then soared by 248.45% to $447.4 million in 2022, then increased by 9.08% to $488.1 million in 2023, then increased by 25.95% to $614.7 million in 2024, then tumbled by 61.69% to $235.5 million in 2025.
  • Per Business Quant, the three most recent readings for ASPN's Common Equity are $235.5 million (Q4 2025), $305.7 million (Q3 2025), and $308.8 million (Q2 2025).